期刊文献+

胸腺上皮肿瘤的临床CT表现与术后存活时间的关系 被引量:6

Correlation between the CT manifestations and post-operative survival time in patients with thymicepithelial tumor
原文传递
导出
摘要 目的分析胸腺上皮肿瘤的临床和CT表现与患者术后存活时间的相关性。方法回顾性复习91例经手术病理证实,并作了WHO病理分类的胸腺上皮肿瘤的CT表现。根据肿瘤大小、形态、边缘、密度、强化程度、纵隔淋巴结、有无大血管侵犯及肺内或胸膜转移灶,并结合是否伴发重症肌无力、WHO病理分类等,评价各因素对患者预后的影响。用Kaplan-Meier法计算总生存率,Logrank检验用于评价各因素间的差异,Cox回归比例风险模型用于多因素分析影响存活的预后因素,X^2检验用于分析CT表现与WHO分类的关系。结果91例中因非肿瘤因素病死2例,其余89例中病死13例,5年总生存率为84.3%(75例)。89例共有病灶91个,在CT表现上肿瘤≥5cm、边缘分叶、密度不均匀、出现血管侵犯、纵隔淋巴结肿大及有远处转移者存活时间较短,5年生存率分别为72.7%、77.3%、76.7%、73.8%、30.0%、68.8%。多因素分析显示肿瘤大小、患者是否合并重症肌无力和是否出现纵隔肿大淋巴结是影响预后的独立影响因素,其偏回归系数(B)分别为0.378、-1.756和1.853,P值分别为0.002,0.009和0.025。CT表现与WHO分类的比较结果和单因素分析结果一致,WHO病理分类不同,则肿瘤的大小、边缘、血管侵犯情况、纵隔淋巴结肿大以及是否有远处转移差异有统计学意义(x。值分别为6.598、5.737、18.307、8.465、15.608,P值均〈0.05)。结论CT表现可以提示肿瘤的生物学特性,肿瘤大小和有无纵隔淋巴结肿大是影响患者存活时间的主要因素,而伴发重症肌无力多提示肿瘤级别较低,患者存活时间相对较长。 explore the correlation between CT findings and post-operative tumor-related survival time. Methods Ninety-one patients who underwent CT scan before operation were reviewed retrospectively. All cases had operation and were classified according to the WHO classification. The size, contour, shape, density and enhancement of the tumors on CT were assessed. Presence of mediastinal lymphadenopathy, great vessel invasion, metastasis to the lung or plural, myasthenia gravis (MG) were also analyzed. The survival rate was obtained using the Kaplan-Meier method. The Cox model was applied to determine the factors affecting the tumor-related survivals. Chi square test was used to analyze the relationship between CT findings and WHO classification. Results Two patients were excluded because of dying of myocardial infarction and colon cancer. The total 5-year survival rate was 84. 3% ( n = 75). Eighty-nine patients had total 91 tumors. Tumors with diameter larger than 5 cm, lobular contour, heterogenous density, and presence of great vessel invasion, mediastinal lymphadenopathy, and metastasis were adverse factors which could significantly affect the survival time. Five-year survival rates of these factors were 72. 7% , 77. 3% , 76. 7% , 73.8% , 30. 0% , and 68.8% , respectively. Presence of MG was a favorable factor which also significantly affected the survival time ( P 〈 0. 05 ). While the shape and enhancement of the tumors and the age, gender of the patients did not significantly affect the survival time ( P 〉 0. 05 ). The result of the Cox multivariate analysis was consistent with that of the Log-rank test. For different WHO classification, there were significant different among the size or contour of the tumors, presence of great vessel invasion, mediastinal lymphadenopathy, and metastasis ( X^2 value were 6. 598, 5. 737, 18. 307, 8. 465, and 15. 608, respectively P 〈 0.05) . Condusions CT findings may be served as predictors of clinical prognosis of the thymic epithelial tumors.Adverse factors for survival time are the size of the tumors and presence of mediastinal lymphadenopathy, while MG is a favorable factor for survival time.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2011年第6期533-537,共5页 Chinese Journal of Radiology
关键词 胸腺肿瘤 体层摄影术 X线计算机 病理学 预后 Thymus neoplasms Tomography, X-ray computed Pathology Prognosis
  • 相关文献

参考文献12

  • 1Chen G,Marx A,Wen-Hu C,et al.New WHO histologic classification predicts prognosis of thymic epithelial tumors:a clinicopathologic study of 200 thymoma cases from China.Cancer,2002,95:420-429.
  • 2Lee HS,Kim ST,Lee J,et al.A single institutional experience of thymic epithelial tumours over 11 years:clinical features and outcome and implications for future management.Br J Cancer,2007,97:22-28.
  • 3Sadohara J,Fujimoto K,Müller NL,et al.Thymic epithelial tumors:comparison of CT and MR imaging findings of low-risk thymomas,high-risk thymomas,and thymic carcinomas.Eur J Radiol,2006,60:70-79.
  • 4Jung KJ,Lee KS,Han J,et al.Malignant thymic epithelial tumors:CT-pathologic correlation.AJR,2001,176:433-439.
  • 5Jeong YJ,Lee KS,Kim J,et al.Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR,2004,183:283-289.
  • 6Kim DJ,Yang WI,Choi SS,et al.Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors.Chest,2005,127:755-761.
  • 7Rea F,Marulli G,Girardi R,et al.Long-term survival and prognostic factors in thymic epithelial tumours.Eur J Cardiothorac Surg,2004,26:412-418.
  • 8Ríos A,Torres J,Galindo PJ,et al.Prognostic factors in thymic epithelial neoplasms.Eur J Cardiothorac Surg,2002,21:307-313.
  • 9Liu W,Tong T,Ji Z,et al.Long-term prognostic analysis of thymectomized patients with myasthenia gravis.Chin Med J (Engl),2002,115:235-237.
  • 10田晓东,张竞,梁朝阳,柳曦,张涛,郭俊唐,刘慧峰,周乃康.93例胸腺瘤按WHO组织分型结果回顾性分析[J].第三军医大学学报,2007,29(9):801-802. 被引量:7

二级参考文献28

  • 1Cameron RB,Loehrer PJ,Thomas CR Jr.Neoplasms of the mediastinum.In:DeVita VT Jr,Hellman S,Rosenberg SA,et al.Cancer:principles and practice of oncology.6th ed.Philadelphia:Lippincott-Raven Publishers,2000:1019-1036.
  • 2Chalabreysse L,Roy P,Cordier JF,et al.Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis.Am J Surg Pathol,2002,26(12):1605-1611.
  • 3Travis WD,Brambilla E,Muller-Hermelink HK,et al.WHO classification of tumors pathology and genetics of tumours of the lung,pleura,thymus and heart.Paris.Lyon:IARC Press,2004:145-197.
  • 4Jeong YJ,Lee KS,Kim J,et al.Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis.AJR Am J Roentgenol,2004,183(2):283-289.
  • 5Nishino M,Ashiku SK,Kocher ON,et al.The thymus:a comprehensive review.Radiographics,2006,26(2):335-348.
  • 6Rieker RJ,Hoegel J,Morresi-Hauf A,et al.Histologic classification of thymic epithelial tumors:comparison of established classification schemes.Int J Cancer,2002,98(6):900-906.
  • 7Okumura M,Ohta M,Tateyama H,et al.The World Health Organization histologic classification system reflects the oncologic behavior of thymoma.Cancer,2002,94(3):624-632.
  • 8Duwe BV,Sterman DH,Musani AI,et al.Tumors of the mediastinum.Chest,2005,128(4):2893-2909.
  • 9Santana L,Givica A,Camacho C,et al.Best cases from the AFIP:thymoma.Radiographics,2002,22:S95-S102.
  • 10Jung KJ,Lee KS,Han J,et al.Malignant thymic epithelial tumors:CT-pathologic correlation.AJR Am J Roentyenol,2001,176(2):433-439.

共引文献28

同被引文献33

  • 1陈晨,尹邦良,魏启幼,胡建国,喻风雷,袁运长,赵元.137例胸腺上皮肿瘤的预后影响因素[J].中南大学学报(医学版),2009,34(4):340-344. 被引量:4
  • 2GIACCONE G. Treatment of malignant thymoma[J]. Curr Opin Oncol, 2005,17 (2): 140-146.
  • 3CHARALAMBOS Z, D IMITRA R, CHARA T, et al. Prognostic factors in thymic epithelial tumors undergoing comp lete resection[J]. Ann Tho rae Surg, 2005,80 (3) : 1056- 1062.
  • 4NISHINO M, ASHIKUS K, KOCHER ON, et al. Thethymus: acomprehensive review [J]. Radlographics, 2006, 26 (2) :335-348.
  • 5Suster S, Moran CA. Histologic classification of thymoma: the World Health Organization and beyond. Hematol Oncol Clin North Am,2008,22 : 381-392.
  • 6Casey EM, Kiel PJ, Loehrer PJ, Sr. Clinical management of thymoma patients. Hematol Oncol Clin North Am, 2008, 22: 457-473.
  • 7Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage m thymic tumors. Ann Thorac Surg,2003,76 : 1866-1872.
  • 8Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer, 1981,48 : 2485-2492.
  • 9Sadohara J, Fujimoto K, Muller NL, et al. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radial ,2006,60 : 70-79.
  • 10Yakushiji S, Tateishi U, Nagai S, et al. Computed tomographie findings and prognosis in thymic epithelial tumor patients. J Comput Assist Tomogr,2008,32 : 799-805.

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部